Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for TRDA

Stock NameEntrada Therapeutics Inc
TickerTRDA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS29384C1080

Show aggregate TRDA holdings

News associated with TRDA

Entrada Therapeutics, Inc. (NASDAQ:TRDA) Receives $25.67 Average Price Target from Brokerages
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) has received an average recommendation of “Buy” from the five brokerages that are covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation, three have given a buy recommendation and one has given a strong buy recommendation to the company. The […] - 2025-09-12 02:01:10
Insider Selling: Entrada Therapeutics, Inc. (NASDAQ:TRDA) Major Shareholder Sells 6,935 Shares of Stock
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) major shareholder Ventures V. L.P. 5Am sold 6,935 shares of the firm’s stock in a transaction dated Wednesday, July 9th. The stock was sold at an average price of $7.50, for a total value of $52,012.50. Following the sale, the insider directly owned 1,093,313 shares of the […] - 2025-07-14 06:12:51
Insider Selling: Entrada Therapeutics, Inc. (NASDAQ:TRDA) Major Shareholder Sells 20,065 Shares of Stock
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) major shareholder Ventures V. L.P. 5Am sold 20,065 shares of the stock in a transaction dated Wednesday, July 9th. The shares were sold at an average price of $7.50, for a total value of $150,487.50. Following the completion of the transaction, the insider owned 3,163,066 shares of […] - 2025-07-14 05:38:49
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Director Sells $202,500.00 in Stock
Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) Director Kush Parmar sold 27,000 shares of the stock in a transaction that occurred on Wednesday, July 9th. The stock was sold at an average price of $7.50, for a total transaction of $202,500.00. Following the sale, the director owned 1,093,313 shares in the company, valued at […] - 2025-07-14 05:38:48
Entrada Therapeutics (NASDAQ:TRDA) Shares Down 3.6% – Should You Sell?
Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Get Free Report) fell 3.6% during mid-day trading on Monday . The company traded as low as $6.87 and last traded at $6.97. 149,403 shares traded hands during trading, an increase of 11% from the average session volume of 134,750 shares. The stock had previously closed at $7.23. […] - 2025-07-08 04:35:07
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 21,594 Shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 152.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 35,750 shares of the company’s stock after acquiring an additional 21,594 shares during […] - 2025-06-12 05:12:44
First Trust Advisors LP Cuts Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
First Trust Advisors LP decreased its position in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 9.6% during the fourth quarter, HoldingsChannel reports. The firm owned 73,749 shares of the company’s stock after selling 7,800 shares during the period. First Trust Advisors LP’s holdings in Entrada Therapeutics were worth $1,275,000 at the end […] - 2025-05-08 05:54:57
Barclays PLC Has $887,000 Holdings in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
Barclays PLC grew its stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 13.9% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 51,365 shares of the company’s stock after purchasing an additional 6,255 shares during the period. Barclays PLC’s holdings in […] - 2025-05-06 04:40:49
Geode Capital Management LLC Cuts Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
Geode Capital Management LLC trimmed its stake in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 0.4% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 573,891 shares of the company’s stock after selling 2,560 shares during […] - 2025-04-23 05:06:55
Entrada Therapeutics, Inc. (NASDAQ:TRDA) Stock Holdings Increased by Federated Hermes Inc.
Federated Hermes Inc. boosted its stake in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 3,104.3% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 99,814 shares of the company’s stock after purchasing an additional 96,699 shares during the period. Federated Hermes Inc. owned about […] - 2025-04-15 04:54:50
Arrowstreet Capital Limited Partnership Has $3.85 Million Stock Position in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
Arrowstreet Capital Limited Partnership increased its stake in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 123.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 222,520 shares of the company’s stock after acquiring an additional 122,823 shares during the quarter. Arrowstreet Capital […] - 2025-04-09 05:30:53
AlphaQuest LLC Invests $70,000 in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
AlphaQuest LLC purchased a new position in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor purchased 4,046 shares of the company’s stock, valued at approximately $70,000. A number of other large investors have also recently made changes to their positions in TRDA. Janus Henderson Group PLC […] - 2025-03-20 06:12:50
Entrada Therapeutics (NASDAQ:TRDA) Receives Buy Rating from HC Wainwright
Entrada Therapeutics (NASDAQ:TRDA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a note issued to investors on Tuesday,Benzinga reports. They currently have a $20.00 price objective on the stock. HC Wainwright’s price target suggests a potential upside of 66.39% from the company’s previous close. TRDA has been […] - 2025-02-27 06:44:55
China Universal Asset Management Co. Ltd. Makes New Investment in Entrada Therapeutics, Inc. (NASDAQ:TRDA)
China Universal Asset Management Co. Ltd. bought a new position in shares of Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund bought 7,931 shares of the company’s stock, valued at approximately $137,000. A number of other […] - 2025-02-04 07:03:05

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) TRDA holdings

DateNumber of TRDA Shares HeldBase Market Value of TRDA SharesLocal Market Value of TRDA SharesChange in TRDA Shares HeldChange in TRDA Base ValueCurrent Price per TRDA Share HeldPrevious Price per TRDA Share Held
2025-11-11 (Tuesday)26,307USD 202,564TRDA holding increased by 11575USD 202,5640USD 11,575 USD 7.7 USD 7.26001
2025-11-10 (Monday)26,307TRDA holding increased by 69USD 190,989TRDA holding increased by 9684USD 190,98969USD 9,684 USD 7.26001 USD 6.91002
2025-11-07 (Friday)26,238USD 181,305TRDA holding decreased by -1049USD 181,3050USD -1,049 USD 6.91002 USD 6.95
2025-11-06 (Thursday)26,238TRDA holding increased by 69USD 182,354TRDA holding increased by 741USD 182,35469USD 741 USD 6.95 USD 6.94001
2025-11-05 (Wednesday)26,169USD 181,613TRDA holding increased by 8374USD 181,6130USD 8,374 USD 6.94001 USD 6.62001
2025-11-04 (Tuesday)26,169TRDA holding increased by 70USD 173,239TRDA holding decreased by -3712USD 173,23970USD -3,712 USD 6.62001 USD 6.77999
2025-11-03 (Monday)26,099USD 176,951TRDA holding decreased by -4437USD 176,9510USD -4,437 USD 6.77999 USD 6.95
2025-10-31 (Friday)26,099USD 181,388TRDA holding increased by 1305USD 181,3880USD 1,305 USD 6.95 USD 6.9
2025-10-30 (Thursday)26,099TRDA holding increased by 350USD 180,083TRDA holding increased by 2672USD 180,083350USD 2,672 USD 6.9 USD 6.89002
2025-10-29 (Wednesday)25,749TRDA holding increased by 140USD 177,411TRDA holding decreased by -10815USD 177,411140USD -10,815 USD 6.89002 USD 7.34999
2025-10-28 (Tuesday)25,609USD 188,226TRDA holding increased by 1024USD 188,2260USD 1,024 USD 7.34999 USD 7.31001
2025-10-27 (Monday)25,609USD 187,202TRDA holding increased by 12293USD 187,2020USD 12,293 USD 7.31001 USD 6.82998
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TRDA by Blackrock for IE00BYXG2H39

Show aggregate share trades of TRDA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY69 7.260* 8.59
2025-11-06BUY69 6.950* 8.61
2025-11-04BUY70 6.620* 8.63
2025-10-30BUY3507.0206.600 6.642USD 2,325 8.67
2025-10-29BUY1406.8907.410 7.358USD 1,030 8.68
2025-10-22SELL-2766.3106.490 6.472USD -1,786 8.74 Profit of 626 on sale
2025-10-20BUY1386.2506.330 6.322USD 872 8.77
2025-10-17BUY3445.8706.245 6.207USD 2,135 8.79
2025-10-15BUY5446.1906.260 6.253USD 3,402 8.81
2025-10-03BUY4906.0006.140 6.126USD 3,002 8.85
2025-10-02BUY705.9206.058 6.044USD 423 8.87
2025-09-30BUY1405.8005.840 5.836USD 817 8.91
2025-09-26BUY1405.8005.918 5.906USD 827 8.96
2025-09-25BUY1405.5805.640 5.634USD 789 8.98
2025-09-18BUY705.5505.755 5.735USD 401 9.03
2025-09-17BUY2105.0905.505 5.464USD 1,147 9.06
2025-08-20SELL-2805.3105.645 5.611USD -1,571 9.17 Profit of 997 on sale
2025-07-30BUY2726.6406.810 6.793USD 1,848 9.34
2025-07-17SELL-1386.3806.625 6.601USD -911 9.58 Profit of 411 on sale
2025-07-11SELL-5606.5506.840 6.811USD -3,814 9.69 Profit of 1,610 on sale
2025-07-07BUY2076.9707.185 7.163USD 1,483 9.78
2025-07-02BUY3,8507.2707.410 7.396USD 28,475 9.83
2025-06-11BUY1407.9008.475 8.418USD 1,178 10.03
2025-06-10BUY1408.2608.490 8.467USD 1,185 10.05
2025-06-04SELL-707.9308.500 8.443USD -591 10.13 Profit of 118 on sale
2025-04-23BUY698.7109.230 9.178USD 633 10.98
2025-04-10SELL-5527.8508.240 8.201USD -4,527 11.48 Profit of 1,808 on sale
2025-04-08SELL-697.5508.720 8.603USD -594 11.61 Profit of 208 on sale
2025-04-07SELL-698.1908.600 8.559USD -591 11.68 Profit of 215 on sale
2025-04-04SELL-3507.9407.990 7.985USD -2,795 11.76 Profit of 1,320 on sale
2025-04-01BUY2,7678.7609.440 9.372USD 25,932 11.88
2025-03-31SELL-1809.0409.430 9.391USD -1,690 11.94 Profit of 459 on sale
2025-03-14SELL-96010.81011.140 11.107USD -10,663 12.42 Profit of 1,259 on sale
2025-03-07SELL-12010.77011.040 11.013USD -1,322 12.68 Profit of 200 on sale
2025-03-04SELL-6010.99011.490 11.440USD -686 12.90 Profit of 87 on sale
2025-02-25BUY12012.12013.170 13.065USD 1,568 13.12
2025-02-19SELL-6013.00013.219 13.197USD -792 13.14 Loss of -3 on sale
2025-02-13BUY18012.63012.850 12.828USD 2,309 13.14
2025-02-12BUY6012.69013.000 12.969USD 778 13.18
2025-02-11BUY24012.24012.910 12.843USD 3,082 13.25
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TRDA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1936,824195155,59423.7%
2025-09-1841,246401,212,8933.4%
2025-09-1758,6450399,87814.7%
2025-09-1612,727095,02513.4%
2025-09-1535,2850104,90733.6%
2025-09-1258,1830119,13148.8%
2025-09-1117,5570105,40916.7%
2025-09-1014,9490113,64513.2%
2025-09-0923,0270100,65522.9%
2025-09-0812,90176156,0678.3%
2025-09-0521,6400150,70414.4%
2025-09-0427,7850118,42023.5%
2025-09-0318,2290125,68414.5%
2025-09-0216,4332,21090,70618.1%
2025-08-2914,176061,03423.2%
2025-08-2815,770038,17241.3%
2025-08-276,024027,55021.9%
2025-08-267,775050,06315.5%
2025-08-2517,366055,13831.5%
2025-08-228,099052,44315.4%
2025-08-2122,119054,64240.5%
2025-08-206,949066,02010.5%
2025-08-1913,372076,56917.5%
2025-08-1813,3452563,17921.1%
2025-08-1531,082072,89942.6%
2025-08-1419,887065,83930.2%
2025-08-1313,070060,87121.5%
2025-08-1225,298069,61936.3%
2025-08-1112,529070,20517.8%
2025-08-0815,1433,49990,45016.7%
2025-08-0799,2668,617168,00259.1%
2025-08-0660,8327,403270,92522.5%
2025-08-0549,3380165,27229.9%
2025-08-0420,0950117,15217.2%
2025-08-0126,3382,93281,35432.4%
2025-07-3155,07150596,54157.0%
2025-07-3025,483061,87341.2%
2025-07-2938,833074,45952.2%
2025-07-2820,413051,42339.7%
2025-07-2515,06019754,27427.7%
2025-07-2412,100037,46732.3%
2025-07-239,6451034,23128.2%
2025-07-2211,506052,74221.8%
2025-07-217,438024,58030.3%
2025-07-187,706031,69724.3%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.